West Pharmaceutical Services stock rises 1.04% and outperforms rivals

8 articles · Updated · MarketWatch · May 1

The shares closed at $300.68 on Friday, extending gains to a third straight session as the S&P 500 rose 0.29% and the Dow fell 0.31%.
West outperformed peers including Abbott Laboratories, down 1.46%, and Baxter International, down 2.10%, while Becton Dickinson edged up 0.18%.
The stock finished 6.72% below its 52-week high of $322.34 reached on 23 October, with trading volume of 642,321 remaining below its 50-day average.

With its CEO retiring amid a historic boom, can West Pharmaceutical defend its market dominance against aggressive competitors?

As new regulations and supply chain risks mount, can this key supplier sustain the flow of critical injectable medicines?